Author： Nicholson Susan Peterson Janet Yektashenas Behin
Publisher： Informa Healthcare
ISSN： 1474-0338
Source： Expert Opinion on Drug Safety, Vol.11, Iss.2, 2012-03, pp. : 299-314
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Risk Evaluation and Mitigation Strategies (REMS): Educating the Prescriber
Drug Safety, Vol. 35, Iss. 2, 2012-02 ,pp. :
Access to resources
Recommend
Caspase Inhibitors: A Pharmaceutical Industry Perspective
Current Topics in Medicinal Chemistry, Vol. 5, Iss. 16, 2005-12 ,pp. :
Challenges in Pediatric Drug Development: A Pharmaceutical Industry Perspective
By Rose Klaus
Pediatric Drugs, Vol. 11, Iss. 1, 2009-01 ,pp. :
Pharmacoeconomics in the New Millennium: A Pharmaceutical Industry Perspective
By Thwaites R.
PharmacoEconomics, Vol. 13, Iss. 2, 1998-02 ,pp. :